Ikena Oncology (IKNA) has released an update.
The Company has announced a significant shift in its leadership team, with Dr. Santillana stepping down and Caroline Germa, M.D. poised to take over as Chief Medical Officer effective February 29, 2024. This change, which is likely to influence the company’s strategic direction, is detailed in a press release and marks a noteworthy moment for investors tracking the company’s management and future prospects.
For further insights into IKNA stock, check out TipRanks’ Stock Analysis page.
